Generating Potent, Stable & Off-the-Shelf Synthetic Tregs from CD4+ Tconv for the Treatment of Colitis & Beyond
Time: 1:30 pm
day: Day 2 Treg Cell Therapy Track PM
Details:
- Outlining the process of converting CD4 cells to synthetic Tregs (synTregs) via gene engineering
- Highlighting the benefits of synTregs compared to tTregs as cellular therapy
- Showcasing preclinical efficacy data from GvHD and colitis mouse models
